E-Prescribing of Controlled Substances (EPCS)
When it comes to E-Prescribing, care providers in the U.S. have to conform to two different sets of regulations: the DEA (Drug Enforcement Administration) and the state board of pharmacy for the state in which they practice. These regulations can introduce barriers in the form of authentication requirements to E-Prescribing adoption.
The Ohio Board of Pharmacy requires two-factor authentication for care providers who prescribe or order medications through E-Prescribing or CPOE. The DEA requires two-factor authentication for E-Prescribing of controlled substances (EPCS).
Imprivata increases care provider adoption of E-Prescribing by eliminating clicks while at the same time supporting both the DEA and state regulations such as the Ohio Board of Pharmacy.
There are incentives and penalties regarding E-Prescribing. Stage 1 Meaningful Use requires that 40% of all prescriptions are electronic. Stage 2 raises the threshold to 65% and introduces an optional requirement for hospitals—a 10% threshold of E-Prescribing at patient discharge. Penalties for Meaningful Use start in 2015; and the CMS MIPPA program penalties have already started.
The DEA ruling on E-Prescribing of Controlled Substances (EPCS) published in 2010 has driven Surescripts, EMR vendors and pharmacy vendors to put the proper controls in place to remove the final barrier to E-Prescribing.
These incentives are driving electronic prescribing adoption—58% of office-based physicians are ePrescribing, up from 36% in 2010 according to Surescripts National Progress Report on ePrescribing from 2011.
How Imprivata Helps EPCS
The state of Ohio and the DEA EPCS ruling both require two-factor authentication. Plus, some E-Prescribing applications require an additional PIN or password --adding additional clicks to physician’s workflow. Imprivata enables authentication directly into the electronic prescribing workflow replacing the extra clicks of entering a PIN or password with the swipe of a fingerprint --supporting all state and federal mandated two-factor authentication modalities. Physicians experience the same fast, secure authentication signing a prescription as they do when logging into the EMR.
Imprivata OneSign provides a single point of management for all authentication needs across your organization, workstation access, application access and secondary authentication. With the broadest range of authentication modalities available Imprivata provides any combination needed to support your specific environment and state laws.
“While meeting the stipulations of the state and other regulating bodies has been an important marker for our progress, the end goal is always providing the best care in the safest environment for our patients. Imprivata has played an integral role in helping us meet that goal.”
–Michael Krouse, Senior Vice President Chief Information Officer OhioHealth
“Meeting the stringent Ohio Board of Pharmacy Positive ID regulations and incorporating those requirements into our CPOE workflow, without burdening the ordering providers, was one of our greatest challenges. By implementing Imprivata Single Sign-On to simplify access to the application, and then using two factor biometric authentication at the point of ordering, we were able to develop a process that not only met the regulatory requirements, but also was extremely easy for the physicians to use.”
-Sallie Arnett, VP Information Systems, Licking Memorial Health Systems
A Planning Guide for E-Prescribing
The DEA regulates prescriptions of controlled substances that have risks for abuse. For healthcare organizations that want to implement ePrescribing for all medications, the need to use manual processes for controlled substances can delay overall ePrescribing adoption.
Request a Demo
Request a demonstration and learn more about Imprivata OneSign.